Diabetic vascular damage

Inhibition of PARP may block hyperglycemia-induced vascular damage

Written byTudor Toma
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Hyperglycemia is important in the pathogenesis of diabetic vascular disease, and the four major molecular mechanisms implicated in hyperglycemia-induced vascular damage reflect a single process: overproduction of superoxide by the mitochondrial electron transport chain. However, the precise pathway by which overproduction of superoxide induces vascular damage has been unclear. In the October 1 Journal of Clinical Investigation, Xueliang Du and colleagues at the Albert Einstein College of Medicine, show that inhibition of GAPDH activity by poly(ADP-ribose) polymerase (PARP) activates three major pathways of hyperglycemic damage in endothelial cells (Journal of Clinical Investigation, 112:1049–1057, October 1, 2003).

Du et al. performed in vitro experiments on bovine aortic endothelial cells and observed that hyperglycemia-induced GAPDH inhibition was a consequence of poly(ADP-ribosyl)ation of GAPDH by PARP—activated by DNA strand breaks produced by mitochondrial superoxide overproduction. In addition, the authors showed that blocking PARP activity with the competitive PARP inhibitors PJ34 or INO-1001 inhibited ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies